Market Tracker

04/23 12:05pm ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

153.61
Real-Time Quote
 -2.49 / -1.60%
Today’s Change
87.01
Today|||52-Week Range
185.43
+15.60%
Year-to-Date

Today’s Trading

Previous close156.10
Today’s open155.97
Day’s range150.21 - 156.98
Volume669,430
Average volume (3 months)1,951,872
Market cap$28.5B
Dividend yield--
Data as of 11:50am ET, 04/23/2014

Growth & Valuation

Earnings growth (last year)-0.78%
Earnings growth (this year)+46.52%
Earnings growth (next 5 years)+29.80%
Revenue growth (last year)+34.85%
P/E ratio120.9
Price/Sales17.19
Price/Book11.92

Competitors

 Today’s
change
Today’s
% change
SHPGShire PLC+1.32+0.83%
FRXForest Laboratories ...+0.04+0.04%
ACTActavis PLC-0.69-0.34%
AGNAllergan Inc+0.56+0.34%
Data as of 12:05pm ET, 04/23/2014

Financials

Next reporting dateApril 24, 2014
EPS forecast (this quarter)$1.28
Annual revenue (last year)$1.5B
Annual profit (last year)$252.9M
Net profit margin16.73%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, Treasurer &
Director
Leonard Bell
Chief Global Operations Officer &
Executive VP
Stephen P. Squinto
Corporate headquarters
Cheshire, Connecticut

Forecasts